Clinical Trial Update: Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase III trial evaluating Hemospan for preventing hypotension (and ischemia risk) during hip arthroplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension
• Ischemia

Drugs mentioned

• Hemospan

Snippet

Sponsor: Sangart | Conditions: Hypotension, Ischemia | Phase 3 | Status: COMPLETED